Camptothecin Induces PD-L1 and Immunomodulatory Cytokines in Colon Cancer Cells

Background: Immunotherapy has changed the options for the treatment of various cancer types, but not colon cancer. Current checkpoint blockade approaches are ineffective in a large proportion of colon cancer cases, necessitating studies to elucidate its mechanisms and to identify new targets and str...

Descripción completa

Detalles Bibliográficos
Autores principales: Bedi, Deepa, Henderson, Henry J., Manne, Upender, Samuel, Temesgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631458/
https://www.ncbi.nlm.nih.gov/pubmed/31022845
http://dx.doi.org/10.3390/medicines6020051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631458/
https://www.ncbi.nlm.nih.gov/pubmed/31022845
http://dx.doi.org/10.3390/medicines6020051

Ejemplares similares